Journal of Antimicrobial Chemotherapy (2001) 48, 455-457
© 2001 The British Society for Antimicrobial Chemotherapy
Correspondence |
Antibiotic resistance in Campylobacter spp. isolated from human faeces (1980–2000) and foods (1997–2000) in Northern Ireland: an update
Northern Ireland Public Health Laboratory, Department of Bacteriology, Belfast City Hospital, Belfast BT9 7AD, UK
Sir,
Thermophilic Campylobacter spp., particularly Campylobacter jejuni and Campylobacter coli, continue to be the faecal pathogens most frequently isolated in Northern Ireland, with approximately 1000 laboratory reports per year.1 Although oral antibiotics are not normally prescribed in the majority of cases, antimicrobial therapeutic intervention may be required owing to the immunocompromised state of the patient or any other predisposing complication. Presently, there are very limited data in the literature on fluoroquinolone resistance in food and human faecal sources from Northern Ireland. Furthermore, as there is growing concern regarding rates of fluoroquinolone resistance in human isolates and the associated employment of similar agents within animal production, a study
Notes
References
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  D. Rao, J. R. Rao, E. Crothers, R. McMullan, D. McDowell, A. McMahon, P. J. Rooney, B. C. Millar, and J. E. Moore Increased erythromycin resistance in clinical Campylobacter in Northern Ireland--an update J. Antimicrob. Chemother., March 1, 2005; 55(3): 395 - 396. [Full Text] [PDF]
|
|
|
|
 |
|
 T. J. Humphrey, F. Jorgensen, J. A. Frost, H. Wadda, G. Domingue, N. C. Elviss, D. J. Griggs, and L. J. V. Piddock Prevalence and Subtypes of Ciprofloxacin-Resistant Campylobacter spp. in Commercial Poultry Flocks before, during, and after Treatment with Fluoroquinolones Antimicrob. Agents Chemother., February 1, 2005; 49(2): 690 - 698. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. Moore and M. Matsuda Fluoroquinolone resistance in environmental urease-positive campylobacters: why we don't see it J. Antimicrob. Chemother., May 1, 2004; 53(5): 891 - 892. [Full Text] [PDF]
|
|
|
|
|
|
A. N. Oza, J. P. McKenna, S. W. J. McDowell, F. D. Menzies, and S. D. Neill Antimicrobial susceptibility of Campylobacter spp. isolated from broiler chickens in Northern Ireland J. Antimicrob. Chemother., August 1, 2003; 52(2): 220 - 223. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Ge, D. G. White, P. F. McDermott, W. Girard, S. Zhao, S. Hubert, and J. Meng Antimicrobial-Resistant Campylobacter Species from Retail Raw Meats Appl. Envir. Microbiol., May 1, 2003; 69(5): 3005 - 3007. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Uzunovic-Kamberovic Antibiotic susceptibility of Campylobacter jejuni and Campylobacter coli human isolates from Bosnia and Herzegovina J. Antimicrob. Chemother., April 1, 2003; 51(4): 1049 - 1051. [Full Text] [PDF]
|
|
|
|
|
|
S. Vacher, A. Menard, E. Bernard, and F. Megraud PCR-Restriction Fragment Length Polymorphism Analysis for Detection of Point Mutations Associated with Macrolide Resistance in Campylobacter spp. Antimicrob. Agents Chemother., March 1, 2003; 47(3): 1125 - 1128. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. J. V. Piddock, V. Ricci, L. Pumbwe, M. J. Everett, and D. J. Griggs Fluoroquinolone resistance in Campylobacter species from man and animals: detection of mutations in topoisomerase genes J. Antimicrob. Chemother., January 1, 2003; 51(1): 19 - 26. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Hakanen, J. Jalava, P. Kotilainen, H. Jousimies-Somer, A. Siitonen, and P. Huovinen gyrA Polymorphism in Campylobacter jejuni: Detection of gyrA Mutations in 162 C. jejuni Isolates by Single-Strand Conformation Polymorphism and DNA Sequencing Antimicrob. Agents Chemother., August 1, 2002; 46(8): 2644 - 2647. [Abstract] [Full Text] [PDF]
|
|